If findings continue to echo results to date, preoperative higher-dose stereotactic radiosurgery could represent a new standard of care for patients with large brain metastases.
Stereotactic radiosurgery, used most often for adult brain tumors, also has promising benefits for pediatric tumors. Dr. Erin Murphy shares results of her study in pilocytic astrocytoma.
More and more of our patients with brain metastases are undergoing stereotactic radiosurgery. Recent outcomes data show it’s paying off in terms of survival and functional performance.
Another large retrospective analysis raises questions around the ARUBA trial’s findings on surgery vs. watch-and-wait for unruptured brain arteriovenous malformations.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The first case series outside Japan suggests this novel approach holds potential advantages over other radiosurgery strategies in survival, convenience and radiobiological effects.
Except for certain targeted agents, the answer is “yes,” a new study shows. But whole-brain radiation should be avoided as initial treatment for patients on systemic therapy.
Quality of life looms so large in trigeminal neuralgia that Cleveland Clinic researchers felt it was high time to study radiosurgery’s impact on well-being in addition to standard pain outcomes.